R Squared’s Amedisys AMED Stock Holding History

R Squared’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,720	Closed	-$252K	–	465
2025 Q1	$252K	Buy	2,720 +480	+21%	+$44.3K	0.27%	154
2024 Q4	$203K	Buy	+2,240	New	+$206K	0.2%	108

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

R Squared's AMED Position: Q2 2025 in Review

R Squared sold out of Amedisys (AMED) in Q2 2025, closing a stake of 2,720 shares — an estimated $252K sold.

R Squared first reported a position in AMED in Q4 2024 and held it in 2 quarters. The position peaked at $252K in Q1 2025. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

R Squared reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
R Squared sold 2,720 Amedisys shares in Q2 2025, an estimated $252K.
R Squared first reported a position in Amedisys in Q4 2024 and held it in 2 quarters.
R Squared's Amedisys position peaked at $252K in Q1 2025.
319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on R Squared's 13F filing for Q2 2025, filed 31 Jul 2025.